Zanubrutinib is Effective in Non-Germinal-center B-cell-like Diffuse Large B-cell Lymphoma with Mutated CD79B, High TCL1A Expression, or Over- Expressed MYC/BCL-2.
LEUKEMIA & LYMPHOMA（2024）
关键词
Diffuse large B-cell lymphoma,CD79B,TCL1A,MYC/BCL-2,zanubrutinib,biomarker
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要